Mind Medicine (MindMed) Inc MMEDF:OTCQB

RT Quote | Exchange | USD
Last | 04/22/21 EDT
2.13quote price arrow down-0.06 (-2.58%)
Volume
1,013,707
52 week range
0.29 - 5.07

...

Loading . . .
  • Open2.21
  • Day High2.21
  • Day Low2.10
  • Prev Close2.13
  • 52 Week High5.07
  • 52 Week High Date12/14/20
  • 52 Week Low0.29
  • 52 Week Low Date06/18/20

Key Stats

  • Market Cap767.07M
  • Shares Out315.91M
  • 10 Day Average Volume1.16M
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change-30.16

KEY STATS

  • Open2.21
  • Day High2.21
  • Day Low2.10
  • Prev Close2.13
  • 52 Week High5.07
  • 52 Week High Date12/14/20
  • 52 Week Low0.29
  • 52 Week Low Date06/18/20
  • Market Cap767.07M
  • Shares Out315.91M
  • 10 Day Average Volume1.16M
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change-30.16

RATIOS/PROFITABILITY

  • EPS (TTM)-0.17
  • P/E (TTM)-12.21
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest From Mind Medicine (MindMed) Inc

There is no recent news for this security.

Latest From Our Partners

There is no recent news for this security.

Profile

MORE
Mind Medicine (MindMed) Inc., formerly Broadway Gold Mining Ltd., is a neuro-pharmaceutical company. The Company discovers, develops and deploys psychedelic inspired medicines to improve health, promote wellness and alleviate suffering. The Company addresses the opioid crisis by developing a non-hallucinogenic version of the psychedelic ibogaine.
Perry Dellelce
Chairman
Jamon Rahn
Chief Executive Officer
Miriam Wernli
President
Carol Nast
Chief Operating Officer
Paul Van Damme
Chief Financial Officer
Bradford Cross
Chief Technology Officer
Address
1166 Alberni Street, Suite 1604
Vancouver, BC
V6E 3Z3
Canada